Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The objective of this prospective phase II protocol is to assess the toxicity and efficacy of
pentoxifylline and SABR in the re-treatment of recurrent or new lung cancers
Phase:
Phase 2
Details
Lead Sponsor:
James Graham Brown Cancer Center University of Louisville
Collaborators:
James Graham Brown Cancer Center University of Louisville
Treatments:
alpha-Tocopherol Pentoxifylline Tocopherols Tocotrienols Vitamin E Vitamins